|

Carboplatin (AUC 5) Clinical Trials

5 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Pipeline

Phase 1: 1Phase 2: 4

Top Sponsors

  • Yang Hong1
  • Xijing Hospital1
  • Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.1
  • CatalYm GmbH1
  • Akeso1

Indications

  • Cancer5
  • Lung Cancer3
  • Advanced Gynecological Malignancies1
  • Stage IIIC Non-Small Cell Lung Cancer1
  • Stage IIIB Non-small Cell Lung Cancer1

Other4 trials

A Study of Ivonescimab in First-Line ES-SCLC
Phase 2
A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
Phase 1
A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors
Phase 2
Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
Phase 2

Birmingham, Alabama1 trial

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.